PuSH - Publication Server of Helmholtz Zentrum München

Oertel, W.H. ; Müller, H.H.* ; Unger, M.M.* ; Schade-Brittinger, C.* ; Balthasar, K.* ; Articus, K.* ; Brinkman, M.* ; Venuto, C.S.* ; Tracik, F.* ; Eberling, J.* ; Eggert, K.M.* ; Kamp, C.* ; Kieburtz, K.* ; Boyd, J.T.*

Transdermal nicotine treatment and progression of early Parkinson's disease.

NEJM Evid. 2:EVIDoa2200311 (2023)
Publ. Version/Full Text DOI PMC
Nicotine Treatment and Parkinson's DiseaseIn this randomized, controlled trial, patients with Parkinson's disease not on dopaminergic therapy were randomly assigned to receive transdermal nicotine or placebo. After 1 year, there was no difference in the change in Total Unified Parkinson's Disease Rating Scale score between groups.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
ISSN (print) / ISBN 2766-5526
e-ISSN 2766-5526
Journal NEJM Evidence
Quellenangaben Volume: 2, Issue: 9, Pages: , Article Number: EVIDoa2200311 Supplement: ,
Publisher NEJM Group
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Neurogenomics (ING)